1-methyl-4-phenylpyridinium has been researched along with Chronic Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
German, DC; Liang, CL; Manzino, L; Sonsalla, PK; Yazdani, U; Zeevalk, GD | 1 |
1 other study(ies) available for 1-methyl-4-phenylpyridinium and Chronic Disease
Article | Year |
---|---|
Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+).
Topics: 1-Methyl-4-phenylpyridinium; Animals; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Injections, Intraventricular; Male; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Survival Rate | 2006 |